Evaluating synergistic versus additive effects of the triplet regimen in metastatic castration-sensitive prostate cancer: a modeling analysis.

This paper evaluates whether the overall survival benefit seen with the ARASENS triplet regimen (androgen-deprivation th...

Continue ReadingEvaluating synergistic versus additive effects of the triplet regimen in metastatic castration-sensitive prostate cancer: a modeling analysis.